Medicinal Products

1513. Deputy Pádraig Rice asked the Minister for Health the status of the commissioned managed access protocol necessary for the reimbursement of a severe asthma biologic medicine for patients with EOS level greater than 300 (details supplied); the delivery timeline; and if she will make a statement on the matter. [29980/25]

1514. Deputy Pádraig Rice asked the Minister for Health the status of the health technology assessment ongoing with the National Centre for Pharmacoeconomics for a biologic medicine to be used for severe asthma patients with EOS level less than 300 (details supplied); the delivery timeline; and if she will make a statement on the matter. [29981/25]

1523. Deputy Barry Heneghan asked the Minister for Health if work has begun to explore early access schemes for certain medicines, as outlined in the Programme for Government; the person in her Department that will have responsibility for this work; if this will include a review of early access schemes already operating in other European countries; and if she will make a statement on the matter. […

1551. Deputy Brian Stanley asked the Minister for Health further to Parliamentary Question No. 787 of 20 May 2025, around the reimbursement list scheme, the answer states that liraglutide (saxenda) is the only product currently approved under community drug schemes GMS/DPS for weight management, to clarify the criteria for use; if a person needs to be in diagnosis of prediabetes or can other facto…

1629. Deputy Claire Kerrane asked the Minister for Health when a drug (details supplied) will be available on the drugs payment scheme to ensure that for those unable to take any form of HRT, now free, can access the alternative for free; and if she will make a statement on the matter. [30656/25]

545. Deputy Noel McCarthy asked the Minister for Health to outline if VYLOY (zolbetuximab-clzb) is currently being reviewed for inclusion in the HSE reimbursement scheme; the status of such a review; and if she will make a statement on the matter. [28541/25]

646. Deputy David Cullinane asked the Minister for Health the estimated cost of reducing the drug payment scheme threshold in increments of €5 to €0, in tabular form. [28743/25]

674. Deputy Conor Sheehan asked the Minister for Health if weight-loss drugs such as ozempic and mounjaro will be made available to medical card patients; her views on whether they should; and if she will make a statement on the matter. [28848/25]

680. Deputy Pádraig Mac Lochlainn asked the Minister for Health if she will advise on a matter raised in correspondence (details supplied). [29078/25]

663. Deputy Brian Stanley asked the Minister for Health if combivent/pulmicort is covered under the GMS Scheme; if not, the reason for its removal; and if she will make a statement on the matter. [26941/25]

681. Deputy Ruth Coppinger asked the Minister for Health if she is aware of a shortage of Ipratropium Steri Neb (Ipramol), Salbutamol, and Atrovent; and if attempts have been made to address this, in light of the dangerous consequences for those reliant on this medication. [26993/25]

767. Deputy James O'Connor asked the Minister for Health if urgent approval will be granted for vyloy (zolbetuximab) which is used for certain types of gastric and gastroesophageal junction cancers (details supplied); and if she will make a statement on the matter. [27575/25]

769. Deputy Pádraig O'Sullivan asked the Minister for Health if she will consider for reimbursement the new treatment VYLOY (zolbetuximab), which is used for certain types of gastric and gastroesophageal junction cancers; and if she will make a statement on the matter. [27585/25]

800. Deputy Pádraig Rice asked the Minister for Health if a drug will be made available to patients for certain types of gastric and gastroesophageal junction cancers under the HSE reimbursement scheme (details supplied); and if she will make a statement on the matter. [27684/25]

802. Deputy Holly Cairns asked the Minister for Health the reason vyloy, also called zolbetuximab, (details supplied) is not currently reimbursed by the HSE under the drug payment scheme despite being approved by the European Medicines Agency; and if she will make a statement on the matter. [27689/25]

805. Deputy Pat Buckley asked the Minister for Health for a fast-tracked review of vyloy (zolbetuximab), which is used for certain types of gastric and gastroesophageal junction cancers, for inclusion in the HSE reimbursement scheme. [27703/25]

806. Deputy Pat Buckley asked the Minister for Health for greater clarity and urgency in addressing access to approved cancer medications in Ireland; and if she will make a statement on the matter. [27704/25]

167. Deputy George Lawlor asked the Minister for Health if she will address the ongoing shortage of estradot (estradiol transdermal) patches in Ireland; if she is aware that women are frequently having to change pharmacies, travel to Northern Ireland, or arrange private courier services to access their prescribed hormone replacement therapy (HRT); if she will comment on reports that general practi…

184. Deputy Sorca Clarke asked the Minister for Health for an update on the review of atropine 0.01%; if consideration has been given to making it available for myopia control; and if she will make a statement on the matter. [26316/25]

185. Deputy Sorca Clarke asked the Minister for Health the criteria for which atropine 0.01% eye drops, prescribed for myopia, to limit the risk of damage to eyes and potentially detached retinas is not on licence, and therefore not covered by the drug payment scheme. [26317/25]

189. Deputy Duncan Smith asked the Minister for Health if there are any proposals to include Venlafaxine in the free HRT scheme, given this is commonly prescribed for women who cannot take HRT due to previous cancer, as this medication is an alternative prescribed for the many women unable to take HRT; and if she will make a statement on the matter. [26372/25]

782. Deputy Paul Murphy asked the Minister for Health if she is aware of the fact that a number of new medicines are being made available through private healthcare providers, while public patients are made to wait for these to become available (details supplied); if she will instruct her Department to ensure that lifesaving medication is made available to all patients; and if she will make a stat…

787. Deputy Brian Stanley asked the Minister for Health if there are any plans to add Ozempic and Saxenda to the list of medications available under the drugs payment scheme for weight loss programmes; and if she will make a statement on the matter. [25199/25]

788. Deputy James Geoghegan asked the Minister for Health to examine concerns in correspondence (details supplied) and outline the measures she is taking to address these. [25210/25]

789. Deputy James Geoghegan asked the Minister for Health for an update on her engagements with representatives of pharmacists in relation to the free HRT scheme; if she will consider raising the dispensing fee for each HRT item (details supplied); and if she will make a statement on the matter. [25211/25]